Private Equity

US

Solera Health inks $42 mln Series C

Phoenix-based Solera Health, a health network, has secured $42 million in Series C funding. HCSC Ventures led the round.

1 min read · 15 May 2019

Solera Health inks $42 mln Series C

Phoenix-based Solera Health, a health network, has secured $42 million in Series C funding. HCSC Ventures led the round.

1 min read · 15 May 2019

Tiger Global leads Series B round for Karat

Seattle-based Karat, which conducts technical interviews on behalf of companies, has raised $28 million in Series B funding. Tiger Global Management led the round with participation from return backers Norwest Venture Partners and 8VC.

1 min read · 15 May 2019

Tiger Global leads Series B round for Karat

Seattle-based Karat, which conducts technical interviews on behalf of companies, has raised $28 million in Series B funding. Tiger Global Management led the round with participation from return backers Norwest Venture Partners and 8VC.

1 min read · 15 May 2019

VC-backed Zipari recruits Poling as chief product officer

Brooklyn, New York-based Zipari, an insurance software startup, has named Mark Poling as chief product officer. Zipari is backed by Vertical Venture Partners.

2 min read · 15 May 2019

Phathom Pharmaceuticals grabs $90 mln

Menlo Park, California-based Phathom Pharmaceuticals, a newly launched biopharmaceutical company focused on treating gastrointestinal diseases and disorders, has secured $90 million in funding. Frazier Healthcare Partners led the round with participation from other investors that included Medicxi, RA Capital Management, Abingworth, certain accounts managed by Janus Henderson Investors, BVF Partners LP, Greenspring Associates, Richard King Mellon Foundation and Sahsen. Also, Phathom has secured a $50 million term loan facility from Silicon Valley Bank.

5 min read · 15 May 2019

Phathom Pharmaceuticals grabs $90 mln

Menlo Park, California-based Phathom Pharmaceuticals, a newly launched biopharmaceutical company focused on treating gastrointestinal diseases and disorders, has secured $90 million in funding. Frazier Healthcare Partners led the round with participation from other investors that included Medicxi, RA Capital Management, Abingworth, certain accounts managed by Janus Henderson Investors, BVF Partners LP, Greenspring Associates, Richard King Mellon Foundation and Sahsen. Also, Phathom has secured a $50 million term loan facility from Silicon Valley Bank.

5 min read · 15 May 2019

Ex-Shepherd GP's Cure8 Ventures raises $2.6 mln toward VC fund

Cure8 Ventures has raised $2.6 million toward a venture-capital fund, according to a filing with the SEC.

1 min read · 14 May 2019

Ex-Shepherd GP's Cure8 Ventures raises $2.6 mln toward VC fund

Cure8 Ventures has raised $2.6 million toward a venture-capital fund, according to a filing with the SEC.

1 min read · 14 May 2019

Spark Capital backs Storr

Storr, an online retail marketplace that enables anyone to buy and sell new, brand-name products, has raised $3 million in additional funding. The investor was Spark Capital. UPDATE: This investment brings Storr's Pre-Series A funding to $7.8 million.

1 min read · 14 May 2019

Showing 4,591 to 4,600 of 41,793 results
1…459461…1000